Flu vaccine for normalizing blood sugar levels: Influenza A/Flu (H1N1) vaccine-based therapy for blood sugar disease: Influenza A/Flu (H1N1) vaccine increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state, via up-regulation of  its target gene Lin28, 20/July/2018, 9.39 am

Flu vaccine preserves your eyes against glaucoma:  Influenza A/Flu (H1N1) vaccine-based therapy for glaucoma: Influenza A/Flu (H1N1) vaccine increases Nmnat1 expression, increases NAD+ levels, improves neuronal dysfunction, and protects against glaucoma,  via down-regulation of its target gene, 20/July/2018,   9.05 am
July 20, 2018
Repurposing the H.Pylori vaccine CTB-UE into a pulmonary arterial hypertension (PAH) vaccine: CTB-UE, a Helicobacter Pyroli vaccine, inhibits the development of pulmonary arterial hypertension via down-regulation of its target gene Notch3, 20/July/2018, 1.22 pm
July 20, 2018
Show all

IntroductionWhat they say:  

A study from the Stem Cell Transplantation Program, Division of Pediatric Hematology/Oncology, Boston Children’s Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts, USA shows that “The Lin28/let-7 axis regulates glucose metabolism.” This study was published, in the 30 September  2011 issue of the Journal “Cell” [One of the best journals in Biological Sciences with an I.F of 28.71] by Prof George Q, the present Dean of the Harvard Medical School, Zhu H, and others.


What we say: 

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that:  Flu vaccine for normalizing blood sugar levels: Influenza A/Flu (H1N1) vaccinebased therapy for blood sugar disease: Influenza A/Flu (H1N1) vaccine increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state, via up-regulation of  its target gene Lin28

 

 


From the significance of the study to Public health relevance: 

Given that: (1) more than 387 million people worldwide are affected by Diabetes mellitus (DM); (2) Diabetes is going to be one of the top 10 causes of death by 2030; (3) the life-long painful injection/drug treatment is required to treat DM; (3) the global economic cost spent for diabetes treatment in 2014 was little more than 600 billion US dollars, there is an urgent need to find: (i) a way to induce regeneration of adult ß-cells and cardiomyocytes that were lost in DM (Diabetes Mellitus) and MI (Myocardial infarction), respectively; (ii) a cheaper alternative to the existing expensive weight-loss drugs; (iii) a side-effect-free natural product-based drug; and (iv) a way to cure, not just treat, diabetes.


What is known?

Prof. George Q and his research team members had shown earlier that loss of Lin28 in muscles promotes insulin resistance and glucose intolerance. 


Research findings to Therapeutic opportunity:

This study suggests, first the first time, Influenza A/flu(H1N1) vaccine-based therapy, with detailed mechanistic insights, for diabetes. Influenza A (H1N1)-vaccine  has been shown to protect against cardiovascular diseases, stroke, and others. However, the mechanism of action remains largely unknown.

Influenza A/Flu (H1N1) vaccine, by increasing the expression of its target gene, it may increase the expression of Lin-28. Thereby, it may (1) increase the expression of IGF1R, INSR, and IRS2; (2) enhance tissue repair; (3) promote regeneration of pancreatic β-cells; (3) augment regenerative capacity; (4) promote insulin sensitivity; and (5) protect against dilated cardiomyopathy (DCM) (Fig.1). Thus, Influenza A/Flu (H1N1) vaccine, either alone or in combination with other drugs,” may be used to treat DM and DCM.

Given the mechanistic insights as to how Influenza A/Flu (H1N1) may function as an anti-hyperglycemic agent, diabetologists, and general practitioners may consider vaccinating their diabetic patients with Influenza A/Flu (H1N1) or beginning a clinical trial. 

[easy_payment currency=”USD”]

Figure 1. Mechanistic insights into how  Influenza A/Flu (H1N1) vaccine functions as an anti-diabetic and cardioprotective agent.  BCG vaccine  may promote insulin sensitivity and protect against myocardial infarction, via up-regulation of reprogramming protein Lin-28

Figure 2.   Influenza A/Flu (H1N1) vaccine may function as an anti-hyperglycemic agent through induction of Lin-28


Details of the research findings: 

Idea Proposed/Formulated (with experimental evidence) by:

Dr. L Boominathan Ph.D.

Amount: $ 500#

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed mechanistic information: How does Influenza A/Flu (H1N1) vaccine promote insulin-sensitized state?

# Research cooperation


References

Web: http://genomediscovery.org or http://newbioideas.com/

CitationBoominathan L, Flu vaccine for normalizing blood sugar levels: Influenza A/Flu (H1N1) vaccinebased therapy for blood sugar disease: Influenza A/Flu (H1N1) vaccine increases the expression of IGF1R, INSR, and IRS2, and promotes an insulin-sensitized state, via up-regulation of  its target gene Lin28, 20/July/2018, 9.39 am,  Genome-2-BioMedicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.